Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin in PWS Infants
NCT03245762Phase 2Completed
- Sponsor
- University of Florida
- Start
- Aug 2017
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxytocin nasal spray in Prader-Willi syndrome (PWS) (2 arms), sponsored by University of Florida. Primary endpoint: Suck and Swallow Competency at Day 6. Started Aug 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT03245762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03245762.